The current is the first study investigating the role of acromegaly metabolic comorbidities on retinal microvasculature, demonstrating that, beyond the direct negative impact of GH and IGF-I excess, also arterial hypertension, impaired glucose metabolism, and high triglycerides levels are capable of getting worse the vascular retinal damage. The gene discussed is GH1; the disease is acromegaly.